These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 39211173)

  • 1. CD11b suppresses TLR7-driven inflammatory signaling to protect against lupus nephritis.
    Li X; Villanueva V; Jimenez V; Nguyen B; Chauhan NR; Khan SQ; Dorschner JM; Jensen MA; Alzahrani K; Wei H; Cimbaluk DJ; Wei DC; Jolly M; Lopez-Rodriguez D; Pineda SB; Barbosa A; Vazquez-Padron RI; Faridi HM; Reiser J; Niewold TB; Gupta V
    bioRxiv; 2024 Jul; ():. PubMed ID: 39211173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD11b Activity Modulates Pathogenesis of Lupus Nephritis.
    Khan SQ; Khan I; Gupta V
    Front Med (Lausanne); 2018; 5():52. PubMed ID: 29600248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD11b agonists offer a novel approach for treating lupus nephritis.
    Villanueva V; Li X; Jimenez V; Faridi HM; Gupta V
    Transl Res; 2022 Jul; 245():41-54. PubMed ID: 35288363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urine soluble urokinase plasminogen activator receptor as a potential biomarker of lupus nephritis activity.
    Burcsár S; Toldi G; Kovács L; Szalay B; Vásárhelyi B; Balog A
    Biomarkers; 2021 Jul; 26(5):443-449. PubMed ID: 33825610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of CD11b Accelerates Lupus Nephritis in Lyn-Deficient Mice Without Disrupting Glomerular Leukocyte Trafficking.
    Gottschalk TA; Hall P; Tsantikos E; L'Estrange-Stranieri E; Hickey MJ; Hibbs ML
    Front Immunol; 2022; 13():875359. PubMed ID: 35634296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD11b activation suppresses TLR-dependent inflammation and autoimmunity in systemic lupus erythematosus.
    Faridi MH; Khan SQ; Zhao W; Lee HW; Altintas MM; Zhang K; Kumar V; Armstrong AR; Carmona-Rivera C; Dorschner JM; Schnaith AM; Li X; Ghodke-Puranik Y; Moore E; Purmalek M; Irizarry-Caro J; Zhang T; Day R; Stoub D; Hoffmann V; Khaliqdina SJ; Bhargava P; Santander AM; Torroella-Kouri M; Issac B; Cimbaluk DJ; Zloza A; Prabhakar R; Deep S; Jolly M; Koh KH; Reichner JS; Bradshaw EM; Chen J; Moita LF; Yuen PS; Li Tsai W; Singh B; Reiser J; Nath SK; Niewold TB; Vazquez-Padron RI; Kaplan MJ; Gupta V
    J Clin Invest; 2017 Apr; 127(4):1271-1283. PubMed ID: 28263189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary levels of the leukocyte surface molecule CD11b associate with glomerular inflammation in lupus nephritis.
    Kitagawa A; Tsuboi N; Yokoe Y; Katsuno T; Ikeuchi H; Kajiyama H; Endo N; Sawa Y; Suwa J; Sugiyama Y; Hachiya A; Mimura T; Hiromura K; Maruyama S
    Kidney Int; 2019 Mar; 95(3):680-692. PubMed ID: 30712924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic cord blood regulatory T cells decrease dsDNA antibody and improve albuminuria in systemic lupus erythematosus.
    Lyu MA; Tang X; Khoury JD; Raso MG; Huang M; Zeng K; Nishimoto M; Ma H; Sadeghi T; Flowers CR; Parmar S
    Front Immunol; 2023; 14():1217121. PubMed ID: 37736101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. suPAR and WT1 modify the adhesion of podocytes and are related to proteinuria in class IV lupus nephritis.
    Bollain-Y-Goytia JJ; Torres-Del-Muro FD; Hernández-Martínez SP; Avalos-Díaz E; Herrera-Esparza R
    J Transl Autoimmun; 2023 Dec; 7():100216. PubMed ID: 37868110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gain-of-function
    Villalvazo P; Carriazo S; Rojas-Rivera J; Ramos AM; Ortiz A; Perez-Gomez MV
    Clin Kidney J; 2022 Nov; 15(11):1973-1980. PubMed ID: 36324999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mTOR inhibitor INK128 attenuates systemic lupus erythematosus by regulating inflammation-induced CD11b
    Shi G; Li D; Li X; Ren J; Xu J; Ding L; Dou H; Hou Y
    Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):1-13. PubMed ID: 30292636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.
    Enocsson H; Wetterö J; Skogh T; Sjöwall C
    Transl Res; 2013 Nov; 162(5):287-96. PubMed ID: 23916811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exposure of female NZBWF1 mice to imiquimod-induced lupus nephritis at an early age via a unique mechanism that differed from spontaneous onset.
    Hayakawa K; Fujishiro M; Yoshida Y; Kataoka Y; Sakuma S; Nishi T; Ikeda K; Morimoto S; Takamori K; Sekigawa I
    Clin Exp Immunol; 2022 May; 208(1):33-46. PubMed ID: 35260898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phoenix from the flames: Rediscovering the role of the CD40-CD40L pathway in systemic lupus erythematosus and lupus nephritis.
    Ramanujam M; Steffgen J; Visvanathan S; Mohan C; Fine JS; Putterman C
    Autoimmun Rev; 2020 Nov; 19(11):102668. PubMed ID: 32942031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LNA-anti-miR-150 ameliorated kidney injury of lupus nephritis by inhibiting renal fibrosis and macrophage infiltration.
    Luan J; Fu J; Chen C; Jiao C; Kong W; Zhang Y; Chang Q; Wang Y; Li D; Illei GG; Kopp JB; Pi J; Zhou H
    Arthritis Res Ther; 2019 Dec; 21(1):276. PubMed ID: 31829247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FKN secreted by kidney epithelial cells regulates macrophage activation in lupus nephritis
    Zuo Y; Pan X; Wang X; You Y
    Lupus; 2023 Oct; 32(12):1381-1393. PubMed ID: 37751892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial Dysfunction in Systemic Lupus Erythematosus with a Focus on Lupus Nephritis.
    Halfon M; Tankeu AT; Ribi C
    Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Splicing machinery is profoundly altered in systemic lupus erythematosus and antiphospholipid syndrome and directly linked to key clinical features.
    Lopez-Pedrera C; Patiño-Trives AM; Cerdó T; Ortega-Castro R; Sanchez-Pareja I; Ibañez-Costa A; Muñoz-Barrera L; Ábalos-Aguilera MC; Ruiz-Vilchez D; Seguí Azpilcueta P; Espinosa M; Barbarroja N; Escudero-Contreras A; Castaño JP; Luque RM; Ortega R; Aguirre MA; Perez-Sanchez C
    J Autoimmun; 2023 Feb; 135():102990. PubMed ID: 36621176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pim-1 as a Therapeutic Target in Lupus Nephritis.
    Fu R; Xia Y; Li M; Mao R; Guo C; Zhou M; Tan H; Liu M; Wang S; Yang N; Zhao J
    Arthritis Rheumatol; 2019 Aug; 71(8):1308-1318. PubMed ID: 30791224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement factor B inhibitor LNP023 improves lupus nephritis in MRL/lpr mice.
    Chen K; Deng Y; Shang S; Tang L; Li Q; Bai X; Chen X
    Biomed Pharmacother; 2022 Sep; 153():113433. PubMed ID: 36076550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.